Datasheet

Lactobacillus casei; C27 (CAT#: LBST-116FG)

Lactobacillus casei is a Gram-positive, facultatively anaerobic, non-motile and non-spore-forming, rod-shaped bacterium that was isolated from dairy products.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

CAT Size Price Quantity  
LBST-116FG
Product Information
Product Overview Lactobacillus casei is a Gram-positive, facultatively anaerobic, non-motile and non-spore-forming, rod-shaped bacterium that was isolated from dairy products.
Target Lactobacillus
Genus Lactobacillus
Strain Designation C27
Application Study and research
Type Strain No
Culture Medium JCM13
Culture Conditions 30°C; Aerobiotic
Source Dairy products
Risk Group 1
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction Lactobacillus species are normal flora of the human mouth, gastrointestinal tract, and female genital tract, where they produce lactic acid and competitively inhibit pathogenic organisms. Lactobacillus are small, slender, nonmotile, Gram-positive bacilli in chains. Immature colonies appear smooth, convex, and translucent. Some species of Lactobacillus used commonly as probiotics. They are most commonly used for diarrhea, including infectious diarrhea and diarrhea in people taking antibiotics. Some people also use lactobacillus for general digestion problems, irritable bowel syndrome; IBS, colic in infants, and many other conditions that involve the stomach and bowel.
Alternative Names Lactobacillus casei; C27
FAQs Customer Reviews Related Products
  1. How is Lactobacillus casei; C27 typically prepared for in vitro experiments?

    Lactobacillus casei; C27 can be prepared by cultivating the bacterial strain in an appropriate growth medium, usually MRS broth or agar, under anaerobic or microaerophilic conditions. The bacterial cells are then collected by centrifugation, washed, and resuspended in buffer or media for use in experiments. Maintaining viability and consistency in preparation is critical for reproducible results.

  2. What is the recommended concentration of Lactobacillus casei; C27 for probiotic studies?

    The optimal concentration of Lactobacillus casei; C27 for probiotic studies typically ranges between 10^6 to 10^9 CFU/mL. However, the exact dosage should be determined based on the specific research objective, whether it's for gut microbiota modulation, immune response studies, or other applications. Higher or lower concentrations might be needed depending on experimental design.

  3. Can Lactobacillus casei; C27 be co-cultured with other bacteria in microbiome research?

    Yes, Lactobacillus casei; C27 can be co-cultured with other bacterial strains in microbiome studies. However, optimizing the media and growth conditions for all bacterial species involved is crucial to ensure that Lactobacillus casei grows effectively without being outcompeted. Careful monitoring of the growth kinetics is recommended.

  4. What are the most reliable methods for quantifying Lactobacillus casei; C27 in mixed microbial communities?

    Quantification can be achieved using quantitative PCR (qPCR) with strain-specific primers to detect Lactobacillus casei; C27 in mixed communities. Additionally, fluorescent in situ hybridization (FISH) or flow cytometry with strain-specific markers can help differentiate it from other microbes.

  5. How can Lactobacillus casei; C27 be administered in animal models?

    Lactobacillus casei; C27 can be administered to animal models via oral gavage, incorporation into feed, or addition to drinking water. The delivery method should be tailored to the study design, and researchers should ensure accurate dosage calculation and a suitable vehicle for bacteria administration to maintain bacterial viability throughout the process.

  • Exceptional Stability for Gut Microbiome Research
    The Lactobacillus casei; C27 strain offered unparalleled stability during gut microbiome studies. It greatly facilitated my research with highly consistent and reproducible results.
  • Ideal for Host-Microbe Interaction Analysis
    In analyzing host-microbe interactions, Lactobacillus casei; C27 demonstrated excellent viability. It provided robust data that enabled deeper insights into bacterial influence on host cells.
  • Enhanced Efficacy in Probiotic Research
    The high viability and activity of Lactobacillus casei; C27 were key in developing potential probiotics for gut health studies. It provided reliable outcomes, exceeding expectations over other similar strains.
  • Perfect for Drug Delivery Studies
    Using Lactobacillus casei; C27 in drug delivery mechanisms allowed me to explore new therapeutic potentials. Its excellent survival and metabolic activity made it a top choice for these research trials.
  • Superior Performance in Immunomodulation Studies
    This strain showed impressive results in modulating immune responses during my drug discovery trials. Creative Biolabs provided a highly reliable product that outperformed others in immunomodulation research applications.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO90012015
Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket
Advertisement